Skip to main content

Table 4 Distribution of all adverse events (1593) by intensity and causality

From: Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial

Grade

Causality

n (%)

Total

Doubtful

Unlikely

Possible

Probable/likely

Highly probable

I

597 (37.5)

107 (6.7)

538 (33.8)

118 (7.4)

19 (1.2)

1379 (86.6)

II

86 (5.4)

49 (3.1)

62 (3.9)

10 (0.6)

1 (0.1)

208 (13.1)

IV

0 (0)

0 (0)

0 (0)

1 (0.1)

0 (0)

1 (0.1)

NA

3 (0.19)

2 (0.13)

0 (0)

0 (0)

0 (0)

5 (0.31)

Total

686 (43.1)

158 (9.9)

600 (37.7)

129 (8.1)

20 (1.3)

1593 (100)

  1. Italic values indicate the relevant safety outcomes